Advanced

Androgen dependent mechanisms of pro-angiogenic networks in placental and tumor development

Metzler, Veronika M.; de Brot, Simone; Robinson, Robert S.; Jeyapalan, Jennie N.; Rakha, Emad; Walton, Thomas; Gardner, David S.; Lund, Emma F.; Whitchurch, Jonathan and Haigh, Daisy, et al. (2017) In Placenta 56. p.79-85
Abstract

The placenta and tumors share important characteristics, including a requirement to establish effective angiogenesis. In the case of the placenta, optimal angiogenesis is required to sustain the blood flow required to maintain a successful pregnancy, whereas in tumors establishing new blood supplies is considered a key step in supporting metastases. Therefore the development of novel angiogenesis inhibitors has been an area of active research in oncology. A subset of the molecular processes regulating angiogenesis are well understood in the context of both early placentation and tumorigenesis. In this review we focus on the well-established role of androgen regulation of angiogenesis in cancer and relate these mechanisms to placental... (More)

The placenta and tumors share important characteristics, including a requirement to establish effective angiogenesis. In the case of the placenta, optimal angiogenesis is required to sustain the blood flow required to maintain a successful pregnancy, whereas in tumors establishing new blood supplies is considered a key step in supporting metastases. Therefore the development of novel angiogenesis inhibitors has been an area of active research in oncology. A subset of the molecular processes regulating angiogenesis are well understood in the context of both early placentation and tumorigenesis. In this review we focus on the well-established role of androgen regulation of angiogenesis in cancer and relate these mechanisms to placental angiogenesis. The physiological actions of androgens are mediated by the androgen receptor (AR), a ligand dependent transcription factor. Androgens and the AR are essential for normal male embryonic development, puberty and lifelong health. Defects in androgen signalling are associated with a diverse range of clinical disorders in men and women including disorders of sex development (DSD), polycystic ovary syndrome in women and many cancers. We summarize the diverse molecular mechanisms of androgen regulation of angiogenesis and infer the potential significance of these pathways to normal and pathogenic placental function. Finally, we offer potential research applications of androgen-targeting molecules developed to treat cancer as investigative tools to help further delineate the role of androgen signalling in placental function and maternal and offspring health in animal models.

(Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Angiogenesis, Epigenetics, Nuclear receptor, VEGF
in
Placenta
volume
56
pages
79 - 85
publisher
W B Saunders
external identifiers
  • scopus:85013422177
  • wos:000406003100015
ISSN
0143-4004
DOI
10.1016/j.placenta.2017.02.018
language
English
LU publication?
yes
id
63a75d83-2edd-40a6-9771-47597e2e7976
date added to LUP
2017-03-16 09:51:50
date last changed
2018-01-14 04:31:00
@article{63a75d83-2edd-40a6-9771-47597e2e7976,
  abstract     = {<p>The placenta and tumors share important characteristics, including a requirement to establish effective angiogenesis. In the case of the placenta, optimal angiogenesis is required to sustain the blood flow required to maintain a successful pregnancy, whereas in tumors establishing new blood supplies is considered a key step in supporting metastases. Therefore the development of novel angiogenesis inhibitors has been an area of active research in oncology. A subset of the molecular processes regulating angiogenesis are well understood in the context of both early placentation and tumorigenesis. In this review we focus on the well-established role of androgen regulation of angiogenesis in cancer and relate these mechanisms to placental angiogenesis. The physiological actions of androgens are mediated by the androgen receptor (AR), a ligand dependent transcription factor. Androgens and the AR are essential for normal male embryonic development, puberty and lifelong health. Defects in androgen signalling are associated with a diverse range of clinical disorders in men and women including disorders of sex development (DSD), polycystic ovary syndrome in women and many cancers. We summarize the diverse molecular mechanisms of androgen regulation of angiogenesis and infer the potential significance of these pathways to normal and pathogenic placental function. Finally, we offer potential research applications of androgen-targeting molecules developed to treat cancer as investigative tools to help further delineate the role of androgen signalling in placental function and maternal and offspring health in animal models.</p>},
  author       = {Metzler, Veronika M. and de Brot, Simone and Robinson, Robert S. and Jeyapalan, Jennie N. and Rakha, Emad and Walton, Thomas and Gardner, David S. and Lund, Emma F. and Whitchurch, Jonathan and Haigh, Daisy and Lochray, Jack M. and Robinson, Brian D and Allegrucci, Cinzia and Fray, Rupert G. and Persson, Jenny L. and Ødum, Niels and Miftakhova, Regina R. and Rizvanov, Albert and Hughes, Ieuan A. and Tadokoro-Cuccaro, Rieko and Heery, David M and Rutland, Catrin S. and Mongan, Nigel P.},
  issn         = {0143-4004},
  keyword      = {Angiogenesis,Epigenetics,Nuclear receptor,VEGF},
  language     = {eng},
  pages        = {79--85},
  publisher    = {W B Saunders},
  series       = {Placenta},
  title        = {Androgen dependent mechanisms of pro-angiogenic networks in placental and tumor development},
  url          = {http://dx.doi.org/10.1016/j.placenta.2017.02.018},
  volume       = {56},
  year         = {2017},
}